Quantcast
Home / Front Page Story / HMO not required to indemnify drug maker for hepatitis C outbreak

HMO not required to indemnify drug maker for hepatitis C outbreak

Two HMOs that a jury found liable for $524 million for retaining a doctor at the center of a hepatitis C outbreak need not pay an additional $280 million to indemnify the drug maker.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top